August 1, 2019

Role of Patient and Disease Factors in Adjuvant Systemic Therapy Decision Making for Early-Stage, Operable Breast Cancer: Update of the ASCO Endorsement of the Cancer Care Ontario Guideline

PUBLICATION: 
Journal of Clinical Oncology 37, no. 22 (August 01, 2019) 1965-1977. DOI: 10.1200/JCO.19.00948.

AUTHORS: 
N. Lynn Henry, MD, PhD; Mark R. Somerfield, PhD; Vandana G. Abramson, MD; Nofisat Ismaila, MD; Kimberly H. Allison, MD; Carey K. Anders, MD; Diana T. Chingos, MS, MFA; Andrea Eisen, MD; Bruno L. Ferrari, MD; Thomas H. Openshaw, MD; Patricia A. Spears, BS; Praveen Vikas, MBBS; and Vered Stearns, MD

SUMMARY: 
ASCO endorsement of Cancer Care Ontario Breast Cancer Guidelines – MP endorsed for clin-high and LN+.

Read more: MammaPrint and BluePrint Molecular…_Henry et al_Journal of Clinical Oncology 2019